The induction of cardiac ornithine decarboxylase by β2‐adrenergic agents is associated with calcium channels and phosphorylation of ERK1/2

AJ López‐Contreras, ME de la Morena… - Journal of Cellular …, 2013 - Wiley Online Library
The role that the induction of cardiac ornithine decarboxylase (ODC), a key enzyme in
polyamine biosynthesis, by beta‐adrenergic agents may have in heart hypertrophy is a …

Overexpression of ornithine decarboxylase decreases ventricular systolic function during induction of cardiac hypertrophy

E Giordano, RA Hillary, TC Vary, AE Pegg, AD Sumner… - Amino Acids, 2012 - Springer
Ornithine decarboxylase (ODC), the first enzyme of polyamine metabolism, is rapidly
upregulated in response to agents that induce a pathological cardiac hypertrophy …

Targeted overexpression of ornithine decarboxylase enhances β-adrenergic agonist-induced cardiac hypertrophy

LM SHANTZ, DJ FEITH, AE PEGG - Biochemical Journal, 2001 - portlandpress.com
These studies were designed to determine the consequences of constitutive overexpression
of ornithine decarboxylase (ODC) in the heart. Induction of ODC is known to occur in …

Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity.

M Nakano, T Kanda, S Matsuzaki… - Research …, 1995 - europepmc.org
Ornithine decarboxylase (ODC, EC 4.1. 1.7), a rate-limiting enzyme in polyamine
biosynthesis, is known to be induced by a beta-adrenoceptor agonist, isoproterenol (ISO) …

Effect of captopril on isoproterenol-induced myocardial ornithine decarboxylase activity

M Shimizu, O Irimajiri, T Nakano, T Mizokami… - Journal of molecular and …, 1991 - Elsevier
Polyamines are thought to play an essential role in cellular hypertrophy and proliferation.
Ornithine decarboxylase (ODC) catalyzes the first and probably the rate-limiting step in …

Overexpression of antizyme in the hearts of transgenic mice prevents the isoprenaline-induced increase in cardiac ornithine decarboxylase activity and polyamines …

CA MACKINTOSH, DJ FEITH, LM SHANTZ… - Biochemical …, 2000 - portlandpress.com
Two lines of transgenic mice were produced with constitutive expression of antizyme-1 in the
heart, driven from the cardiac α-myosin heavy chain promoter. The use of engineered …

Central role for ornithine decarboxylase in β-adrenoceptor mediated hypertrophy

KD Schlüter, K Frischkopf, M Flesch… - Cardiovascular …, 2000 - academic.oup.com
Objective: TGF-β stimulation of cardiac myocytes induces a hypertrophic responsiveness to
β-adrenoceptor stimulation. This study investigates whether this β-adrenoceptor mediated …

[HTML][HTML] Evidence that AMP-activated protein kinase can negatively modulate ornithine decarboxylase activity in cardiac myoblasts

CL Passariello, D Gottardi, S Cetrullo, M Zini… - … et Biophysica Acta (BBA …, 2012 - Elsevier
The responses of AMP-activated protein kinase (AMPK) and Ornithine decarboxylase (ODC)
to isoproterenol have been examined in H9c2 cardiomyoblasts, AMPK represents the link …

beta 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivo.

JG Copeland, DF Larson, WR Roeske… - British Journal of …, 1982 - ncbi.nlm.nih.gov
The pharmacological characteristics of the myocardial adrenoceptor of the mouse have
been examined during embryogenesis by measuring ornithine decarboxylase (ODC, EC …

Downregulation of the ornithine decarboxylase/polyamine system inhibits angiotensin-induced hypertrophy of cardiomyocytes through the NO/cGMP-dependent …

Y Lin, JC Liu, XJ Zhang, GW Li, LN Wang… - Cellular Physiology and …, 2010 - karger.com
Background: Polyamines and nitric oxide (NO) have been involved in the pathogenesis of
cardiac hypertrophy. NO can regulate cardiac ion channels by direct actions on G-proteins …